Skip to main content

Nasdaq IPOs

Cancer biotech Instil Bio sets terms for $250 million IPO

5 years 6 months ago
Instil Bio, an early stage biotech developing cell therapies for cancer, announced terms for its IPO on Monday. The Dallas, TX-based company plans to raise $250 million by offering 13.9 million shares at a price range of $17 to $19. At the midpoint of the proposed range, Instil
Renaissance Capital

Defense contractor Leonardo DRS sets terms for $670 million IPO

5 years 6 months ago
Leonardo DRS, a defense product and technology provider being spun out of Leonardo, announced terms for its IPO on Monday. The Arlington, VA-based company plans to raise $670 million by offering 31.9 million shares (100% insider) at a price range of $20 to $22. At the midpoint o
Renaissance Capital

Web development platform DigitalOcean sets terms for $751 million IPO

5 years 6 months ago
DigitalOcean, which offers cloud computing services and web development tools to SMBs, announced terms for its IPO on Monday. The New York, NY-based company plans to raise $751 million by offering 16.5 million shares at a price range of $44 to $47. Tiger Global and insider Acces
Renaissance Capital
Checked
23 minutes 13 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed